Biocides

MustGrow Investor Webcast Today - Tuesday May 4th at 4:10pm ET

Retrieved on: 
Tuesday, May 4, 2021

This natural biological approach to crop protection underscores the "E" in ESG - Environmental, Social, and Governance.

Key Points: 
  • This natural biological approach to crop protection underscores the "E" in ESG - Environmental, Social, and Governance.
  • MustGrow has designed and owns a U.S. EPA-approved natural solution that uses the mustard seed\'s natural defence mechanism to protect plants from pests and diseases.
  • Over 110 independent tests have been completed, validating MustGrow\'s safe and effective signature products.
  • MustGrow has now concentrated a mustard extract biopesticide in liquid format, TerraMG, and with regulatory approval, could be applied through standard drip or spray equipment, improving functionality and performance features.

Insights on the Crop Protection Chemicals Global Market to 2025 - Size, Trends & Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, April 30, 2021

b'3.1.2 Global Crop Protection Chemicals (CPC) Market by Segments (herbicides, fungicides, insecticides, and other crop protection chemicals)\n3.1.2 Global Crop Protection Chemicals (CPC) Market by Country (India, Brazil and ROW)\n3.2 Global Crop Protection Chemicals (CPC) Market: Segment Analysis\n'

Key Points: 
  • b'3.1.2 Global Crop Protection Chemicals (CPC) Market by Segments (herbicides, fungicides, insecticides, and other crop protection chemicals)\n3.1.2 Global Crop Protection Chemicals (CPC) Market by Country (India, Brazil and ROW)\n3.2 Global Crop Protection Chemicals (CPC) Market: Segment Analysis\n'

$83.5 Billion Crop Protection Chemicals Market - Global Industry Analysis 2017-2020 & Growth Trends and Market Forecast 2021-2025 - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 29, 2021

b'The "Crop Protection Chemicals Market - Global Industry Analysis (2017 - 2020), Growth Trends and Market Forecast (2021 - 2025)" report has been added to ResearchAndMarkets.com\'s offering.\nDriven by the rising demand for improved crop yield, the crop protection chemicals market is forecast to surpass US$ 83.5 Bn by 2025, growing at a 5.3% CAGR\nWith global population expected to surpass 9.8 billion by 2025, the pressure is increasing on arable land, which is already on decline.

Key Points: 
  • b'The "Crop Protection Chemicals Market - Global Industry Analysis (2017 - 2020), Growth Trends and Market Forecast (2021 - 2025)" report has been added to ResearchAndMarkets.com\'s offering.\nDriven by the rising demand for improved crop yield, the crop protection chemicals market is forecast to surpass US$ 83.5 Bn by 2025, growing at a 5.3% CAGR\nWith global population expected to surpass 9.8 billion by 2025, the pressure is increasing on arable land, which is already on decline.
  • Thanks to favorable regulations and conducive environment for growth, the crop protection chemicals market is exhibiting impressive growth.
  • Of these, Latin America is expected to register growth at an accelerated pace over the course of the report\'s forecast period.
  • However, restructuring of crop protection chemicals market in China could derail growth of pesticides consumption to an extent.\nCompanies operating in the market have been focusing on strategic collaborations.

Soft-Tex International, Inc. Expands Antimicrobial Product Protection Offerings in Partnership with Microban International

Retrieved on: 
Thursday, April 29, 2021

b'WATERFORD, N.Y., April 29, 2021 /PRNewswire/ --Soft-Tex International Inc., a leading innovator of sleep and home comfort products, today announced an expanded suite of antimicrobial treated bedding offerings through an expanded partnership with Microban International, the global leader in antimicrobial solutions.

Key Points: 
  • b'WATERFORD, N.Y., April 29, 2021 /PRNewswire/ --Soft-Tex International Inc., a leading innovator of sleep and home comfort products, today announced an expanded suite of antimicrobial treated bedding offerings through an expanded partnership with Microban International, the global leader in antimicrobial solutions.
  • The unique patented technologies contain ultra-fine silver crystals that release silver ions at a controlled rate only when the conditions for bacterial growth exist.
  • Microban drives innovation by combining science and creative solutions that enhance high-quality consumer, textile, industrial and medical products around the world.
  • Today the Microban brand and technologies are featured on thousands of products worldwide.

SiShield's Antimicrobial Disinfectant and Surface Coating (SiS 200D RTU) Has Been Added to the Environmental Protection Agency's List N: Disinfectants for Use Against SARS-CoV-2 (COVID-19)

Retrieved on: 
Wednesday, April 28, 2021

When tested at an GLP accredited laboratory, SiS 200D RTU was found to eliminate99.99% ofHuman Coronavirus Strain 229 E, ATCC VR-740 on hard, nonporous environmental surfaces, at a contact time of 10 minutes.

Key Points: 
  • When tested at an GLP accredited laboratory, SiS 200D RTU was found to eliminate99.99% ofHuman Coronavirus Strain 229 E, ATCC VR-740 on hard, nonporous environmental surfaces, at a contact time of 10 minutes.
  • It is the world's firstpatented water-based, durable, non-toxic, relatively safe, and non-flammable, non-leaching and non-migrating (after it is bound), odorless and colorless disinfectant and microbiostatic agent.
  • SiShield's mission is to be the leading supplier of antimicrobial products through innovation, vast experience, and dedication to meeting its customer's antimicrobial needs.
  • For more information on the patented technology, please visit www.sishield.com .\nWe are actively monitoring [email protected] for press inquiries.\n"

Antiviral Therapeutics Markets, Technologies, & Competitive Landscape Report 2021-2030 Featuring profiles of 195 Companies with 179 Collaborations

Retrieved on: 
Tuesday, April 27, 2021

SWOT (strengths, weaknesses, opportunities and threats) analysis of antiviral approaches is presented against the background of concept of an ideal antiviral agent.\nA novel feature of this report is the use of nanotechnology in virology and its potential for antiviral therapeutics.

Key Points: 
  • SWOT (strengths, weaknesses, opportunities and threats) analysis of antiviral approaches is presented against the background of concept of an ideal antiviral agent.\nA novel feature of this report is the use of nanotechnology in virology and its potential for antiviral therapeutics.
  • Various methods for local as well as systemic delivery of antiviral agents and vaccines are described.
  • Antiviral markets are estimated starting with 2020 with projections up to the year 2030.\nProfiles of 195 companies that are involved in developing various technologies and products are profiled and with 179 collaborations.
  • These include major pharmaceutical companies (12), Biopharmaceutical companies with antiviral products (87), Antiviral drug companies (26) as well as viral vaccine companies (71).

ContraFect Invited to Participate in the Cystic Fibrosis Target Product Profile Virtual Symposium

Retrieved on: 
Monday, April 26, 2021

The symposium has been established by the CF Syndicate in Antimicrobial Resistance (AMR) and is supported by the Cystic Fibrosis Trust and The Medicines Discovery Catapult, both United Kingdom based organizations fostering cutting edge therapeutic research.

Key Points: 
  • The symposium has been established by the CF Syndicate in Antimicrobial Resistance (AMR) and is supported by the Cystic Fibrosis Trust and The Medicines Discovery Catapult, both United Kingdom based organizations fostering cutting edge therapeutic research.
  • An estimated 700,000 deaths worldwide each year are attributed to antimicrobial-resistant infections.
  • We intend to address life threatening infections using our therapeutic product candidates from our platform of DLAs, which include lysins and amurin peptides.
  • Important factors that could cause actual results to differ include, among others, our ability to develop treatments for drug-resistant infectious diseases.

Global Sterilization Container Systems Market 2021-2026 - A USD 375 Million Market by 2026 - ResearchAndMarkets.com

Retrieved on: 
Friday, April 23, 2021

b'The "Global Sterilization Container Systems Market by Product (Sterilization Containers, Accessories), Type (Perforated, Non-Perforated), Material (Stainless Steel, Aluminium, Other Materials), Technology (Filter, Valve), and Region - Forecast to 2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe global sterilization container systems market is projected to reach USD 375 million by 2026 from USD 324 million in 2021, at a CAGR of 3% during the forecast period.\nThe market growth is primarily driven by the rising incidence of hospital-acquired infections and the increasing number of surgical procedures.

Key Points: 
  • b'The "Global Sterilization Container Systems Market by Product (Sterilization Containers, Accessories), Type (Perforated, Non-Perforated), Material (Stainless Steel, Aluminium, Other Materials), Technology (Filter, Valve), and Region - Forecast to 2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe global sterilization container systems market is projected to reach USD 375 million by 2026 from USD 324 million in 2021, at a CAGR of 3% during the forecast period.\nThe market growth is primarily driven by the rising incidence of hospital-acquired infections and the increasing number of surgical procedures.
  • The sterilization container systems market is segmented based on product, type, technology, material, and region.\nGeographically, the sterilization container systems market is segmented into North America, Europe, the Asia-Pacific, and the Rest of the World.
  • In 2019, North America accounted for the largest share of the sterilization container systems market.
  • The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total sterilization container systems market.

Global Antiviral Therapeutics Markets & Technologies Report 2021: Approaches, Vaccines, Human Coronaviruses, Nanotechnology, Delivery, Competitive Landscape, 2020-2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 21, 2021

Various antiviral approaches are described including pharmaceuticals and molecular biological therapies such as gene therapy and RNA interference (RNAi) as well as vaccines for virus infections.

Key Points: 
  • Various antiviral approaches are described including pharmaceuticals and molecular biological therapies such as gene therapy and RNA interference (RNAi) as well as vaccines for virus infections.
  • Various methods for local as well as systemic delivery of antiviral agents and vaccines are described.
  • These include major pharmaceutical companies (12), Biopharmaceutical companies with antiviral products (87), Antiviral drug companies (26) as well as viral vaccine companies (71).
  • The report is supplemented with 57 tables, 17 figures and 550 references from the literature.\n'

Nearly half a million dollars to fund a research chair to ensure food safety and quality

Retrieved on: 
Thursday, April 22, 2021

b'MONTRAL and LAVAL, QC, April 22, 2021 /CNW Telbec/ - What are the antimicrobial effects of stabilized natural products to ensure food safety and quality?

Key Points: 
  • b'MONTRAL and LAVAL, QC, April 22, 2021 /CNW Telbec/ - What are the antimicrobial effects of stabilized natural products to ensure food safety and quality?
  • This funding will make it possible to develop different stabilization methods, such as food coating via immobilization in edible polymers.
  • "\nThe project is also evaluating the possible interactions between food composition, processing and storage conditions, and the resulting antimicrobial activity.
  • I am already looking forward to the advances that the work of the chair in food safety and quality will allow.